Table 2.

Target LDL-cholesterol (LDL-C) levels in relation to the cardiovascular profile in three guidelines published one year after other: 2018 Polish Cardiac Society (PCS) Working Group on Cardiovascular Pharmacotherapy and 2019 Polish Society of Hypertension (PSH) – 2018/2019 PCS/PSH, 2019 European Society of Cardiology/European Atherosclerosis Society – 2019 ESC/EAS, and 2020 International Society of Hypertension – 2020 ISH.

Risk category	2018/2019 PCS/PSH	2019 ESC/EAS	2020 ISH
Extremely high	<35 mg/dL (<0,9 mmol/L)	<40 mg/dL (<1 mmol/L)∗ ∗ Only for those who experience a second vascular event within 2 years (not necessarily of the same type as the first event) while taking maximally toleratedstatin-based therapy,
Very high	LDL <55 mg/dL (<1,4 mmol/L)	LDL <55 mg/dL (<1,4 mmol/L)	LDL <70 mg/dL (<1,8 mmol/L) ∗ ∗ < 55 mg.dL (<1.4 mmoVL) only for those with arterial hypertension and coronary artery disease
High	<70 mg/dL (<1,8 mmol/L)	<70 mg/dL (<1,8 mmol/L)	<100 mg/dL (<1,8 mmol/L)
Moderate	<100 mg/dL (<2,6 mmol/L)	<100 mg/dL (<2,6 mmol/L)	<115 mg/dL (<2,6 mmol/L)
Low	<115 mg/dL (<3,0 mmol/L)	<115 mg/dL (<3,0 mmol/L)